Seelos Therapeutics Announces Additional Interim Data from Phase I Studies of Intranasal Racemic Ketamine (SLS-002)
26 févr. 2020 08h01 HE
|
Seelos Therapeutics, Inc.
NEW YORK, Feb. 26, 2020 (GLOBE NEWSWIRE) -- Seelos Therapeutics, Inc. (Nasdaq: SEEL), a clinical-stage biopharmaceutical company focused on the development of therapies for central nervous system...
Operation Lifesaver introduces resource for news media reporting on suicide-related rail incidents
14 janv. 2020 10h00 HE
|
Operation Lifesaver
Washington, Jan. 14, 2020 (GLOBE NEWSWIRE) -- Operation Lifesaver, Inc., (OLI) the national, nonprofit rail safety education organization, is providing a new resource that offers effective messaging...
Seelos Therapeutics Announces Interim Data from Phase I Study of Intranasal Racemic Ketamine (SLS-002)
10 janv. 2020 07h31 HE
|
Seelos Therapeutics, Inc.
NEW YORK, Jan. 10, 2020 (GLOBE NEWSWIRE) -- Seelos Therapeutics, Inc. (Nasdaq: SEEL), a clinical-stage biopharmaceutical company focused on the development of therapies for central nervous system...
Seelos Therapeutics Schedules Type C Meeting with FDA to Discuss Intranasal Racemic Ketamine Program (SLS-002)
06 janv. 2020 08h02 HE
|
Seelos Therapeutics, Inc.
NEW YORK, Jan. 06, 2020 (GLOBE NEWSWIRE) -- Seelos Therapeutics, Inc. (Nasdaq: SEEL), a clinical-stage biopharmaceutical company focused on the development of therapies for central nervous system...
Highmark Interactive to Launch Therapeutic Trials Using Software to Treat Concussion, Mental Health and More
05 déc. 2019 09h10 HE
|
Highmark Interactive
TORONTO, Dec. 05, 2019 (GLOBE NEWSWIRE) -- Highmark Interactive, an award-winning digital health company, is announcing their intention to begin therapeutic trials utilizing their FDA-cleared ‘EQ...
Seelos Therapeutics Announces Dosing of Phase I PK/PD Study of Intranasal Racemic Ketamine (SLS-002)
27 nov. 2019 11h00 HE
|
Seelos Therapeutics, Inc.
NEW YORK, Nov. 27, 2019 (GLOBE NEWSWIRE) -- Seelos Therapeutics, Inc. (Nasdaq: SEEL), a clinical-stage biopharmaceutical company focused on the development of therapies for central nervous system...
New Report Reveals Worsening Disparities in Access to Behavioral Healthcare for Employer-Sponsored Health Plans
20 nov. 2019 10h16 HE
|
The Bowman Family Foundation
-Addiction Treatment Disparities for Inpatient, Outpatient Facility, and Office Visits are Stark Despite the National Opioid Crisis -Children’s Use of Out-of-Network Mental Health Office Visits is...
Trupanion Supports Australia’s Veterinary Professionals in their Mental Wellbeing through MightyVet
15 oct. 2019 15h37 HE
|
Trupanion
MightyVet connects industry professionals in Australia and beyond with valuable resources Focuses on burnout, compassion fatigue, ethics exhaustion, resiliency, and suicide prevention SEATTLE, Oct. ...
American Addiction Centers Partners With Former BMX Elite Pro Tony Hoffman in New Documentary on the Power of Redemption and Recovery
10 oct. 2019 15h08 HE
|
American Addiction Centers, Inc.
BRENTWOOD, Tenn., Oct. 10, 2019 (GLOBE NEWSWIRE) -- American Addiction Centers (AAC), a leading provider of substance use treatment services, released the latest installment of its new docuseries,...
Children's Hospital Launches Bold Initiative to Address Mental Health Crisis
17 sept. 2019 17h28 HE
|
Children's Hospital of The King's Daughters
Norfolk, Va, Sept. 17, 2019 (GLOBE NEWSWIRE) -- Eric and Michelle Peterson live every day with the fact that there’s nothing they can do to bring back their daughter, Sarah, who died by suicide five...